Related references
Note: Only part of the references are listed.The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients
B.R. Don et al.
CLINICAL NEPHROLOGY (2013)
Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection
Nicoletta Cassano et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Methotrexate should not be used for patients with end-stage kidney disease
O. Boey et al.
ACTA CLINICA BELGICA (2006)
Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis
M Hammoudeh
RHEUMATOLOGY (2006)
The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
BR Don et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
A Fernández-Nebro et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Dosing of antirheumatic drugs in renal disease and dialysis
A Swarup et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2004)
A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey
S Tuglular et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Share Paper
